Literature DB >> 25796160

Curative effect of lauromacrogol and absolute ethyl alcohol injection guided by ultrasound on simplex hepatic cyst.

Jie Xue1, Xianhui Geng2.   

Abstract

This research aims to analyze the curative effect and security of lauromacrogol injection and absolute ethyl alcohol treating simplex hepatic cyst respectively. The simplex hepatic cyst patients were divided into lauromacrogol group (86 cases, research group) and absolute ethyl alcohol group (80 cases, control group). Both two groups received sclerotherapy of thoracic drainage under ultrasonic guidance and the curative effect and untoward effect were observed. The result showed there was no hemorrhage or infection within two groups. During the therapeutic process, 45 patients (56.3%) suffered from pain at different degrees and 23 cases were found with symptom of drunkenness in control group, while the patients in the research group were found with no obvious discomfort. A week after treatment, 23 patients (25.0%) in control group still remained to have swelling pain at upper right stomach, while there were only 9 in treatment group (10.5%), and the difference was of statistical significance (X(2)=6.037, P<0.05). through 6 months of follow-up visit after the operation, we found the cure rate of lauromacrogol group was 94.6% and absolute ethyl alcohol was 92.6%, and the difference between these two groups was of no statistical significance (P>0.05). The results showed that, in the treatment of cystosclerosis with absolute ethyl alcohol injection under ultrasonic guidance, some patients suffered pain and the symptom of drunkenness at different degrees, whereas, lauromacrogol was effective with no untoward effects, therefore it is worthy of clinical popularization and application.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25796160

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  5 in total

1.  Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results.

Authors:  Xiaohua Gong; Qi Zhou; Fang Wang; Wenjun Wu; Xiaojun Chen
Journal:  Int J Endocrinol       Date:  2017-05-31       Impact factor: 3.257

2.  Percutaneous Lauromacrogol Foam Sclerotherapy for the Treatment of Acute Airway Compression Caused by Lymphatic Malformations in Infants.

Authors:  Lidan Wang; Fan Liu; Sui Huang
Journal:  Biomed Res Int       Date:  2018-10-18       Impact factor: 3.411

3.  Efficacy Assessment of Ultrasound Guided Lauromacrogol Injection for Ablation of Benign Cystic and Predominantly Cystic Thyroid Nodules.

Authors:  Yijie Dong; Jianqiao Zhou; Zhenhua Liu; Ting Luo; Weiwei Zhan
Journal:  Front Pharmacol       Date:  2019-05-08       Impact factor: 5.810

4.  Ultrasound-Guided Lauromacrogol Injection for the Treatment of Active Bleeding After Renal Biopsy.

Authors:  Weizong Liu; Chunchun Jin; Qingshu Lian; Lifeng Xu; Zhanye Lin; Jianghao Lu; Xuehao Gong
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

5.  Efficacy of Lauromacrogol Injection for Ablation of Benign Predominantly Cystic Thyroid Nodules and Related Factors: A Prospective Study.

Authors:  Yi Jie Dong; Zhen Hua Liu; Jian Qiao Zhou; Wei Wei Zhan
Journal:  Korean J Radiol       Date:  2022-04       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.